05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
On March 19, 2020, Governor Newsom issued a “Safer at Home” Order, which generally permits constru...
Read More >
Amid the exponential increase of COVID-19 cases in the State of New York and, more specifically in N...
Read More >
In its groundbreaking decision in Epic Systems Corp. v. Lewis, 584 US ___, 138 S. Ct. 1612 (2018), t...
Read More >
With the world still grappling with the outbreak of COVID-19, companies across a variety of industri...
Read More >
With the departure of Alexander Acosta as Secretary of Labor, the Department immediately got an acti...
Read More >
U.S. Citizenship and Immigration Services (USCIS) recently announced that it would begin accepting e...
Read More >